Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 10,050
+480 (5.02%)
Last updated: Mar 10, 2026, 9:52 AM KST
Prestige BioPharma Balance Sheet
Financials in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Cash & Equivalents | 76,387 | 115,378 | 219,433 | 125,022 | 268,651 | 458,975 | Upgrade
|
| Short-Term Investments | 8,576 | 58,334 | 3,058 | 176,390 | 25,584 | - | Upgrade
|
| Trading Asset Securities | - | - | - | - | 9,035 | 377.68 | Upgrade
|
| Cash & Short-Term Investments | 84,964 | 173,712 | 222,492 | 301,412 | 303,270 | 459,353 | Upgrade
|
| Cash Growth | -65.02% | -21.92% | -26.18% | -0.61% | -33.98% | 849.10% | Upgrade
|
| Accounts Receivable | 2,465 | 607.07 | 391.6 | 132.72 | - | - | Upgrade
|
| Receivables | 2,465 | 607.07 | 391.6 | 132.72 | - | - | Upgrade
|
| Inventory | 30,429 | 26,995 | 18,103 | 7,146 | 2,157 | - | Upgrade
|
| Prepaid Expenses | 2,494 | 1,641 | 2,733 | 2,731 | - | - | Upgrade
|
| Other Current Assets | 545.27 | 7,049 | 6,632 | 53.44 | 6,139 | 584.08 | Upgrade
|
| Total Current Assets | 120,897 | 210,004 | 250,352 | 311,476 | 311,566 | 459,937 | Upgrade
|
| Property, Plant & Equipment | 340,129 | 341,657 | 327,062 | 310,438 | 38,342 | 6,437 | Upgrade
|
| Long-Term Investments | - | - | - | - | 74,710 | 24,159 | Upgrade
|
| Goodwill | 11,139 | 10,530 | 10,785 | 10,192 | - | - | Upgrade
|
| Other Intangible Assets | 31,559 | 30,056 | 31,327 | 29,877 | 4,288 | 450.33 | Upgrade
|
| Long-Term Deferred Charges | 161,452 | 152,882 | 91,643 | 78,843 | 61,024 | 108,573 | Upgrade
|
| Other Long-Term Assets | 664.37 | 525.18 | 551.5 | 775.14 | 9,883 | 4,611 | Upgrade
|
| Total Assets | 665,841 | 745,654 | 711,720 | 741,600 | 499,813 | 604,166 | Upgrade
|
| Accounts Payable | 4,365 | 5,864 | 2,282 | 462.15 | 2,624 | - | Upgrade
|
| Accrued Expenses | 2,829 | 4,872 | 5,975 | 6,150 | 4,923 | 3,552 | Upgrade
|
| Short-Term Debt | 49,336 | 95,939 | 36,954 | 31,188 | - | 2,873 | Upgrade
|
| Current Portion of Long-Term Debt | 10,855 | 14,083 | 10,891 | 31,176 | - | - | Upgrade
|
| Current Portion of Leases | 797.6 | 1,018 | 950.81 | 1,682 | 1,593 | 1,326 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 565 | Upgrade
|
| Other Current Liabilities | 49,547 | 43,546 | 88,805 | 64,231 | 32,654 | 5,730 | Upgrade
|
| Total Current Liabilities | 117,729 | 165,322 | 145,857 | 134,888 | 41,794 | 14,046 | Upgrade
|
| Long-Term Debt | 27,136 | 32,498 | 40,247 | 50,190 | - | - | Upgrade
|
| Long-Term Leases | 496.63 | 641.93 | 624.04 | 1,326 | 2,656 | 3,571 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 25,427 | 11,588 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 7,571 | 7,310 | 7,755 | 7,368 | - | - | Upgrade
|
| Other Long-Term Liabilities | 30,343 | 31,572 | 1,734 | 1,593 | 0 | - | Upgrade
|
| Total Liabilities | 183,276 | 237,343 | 196,219 | 195,365 | 69,877 | 29,206 | Upgrade
|
| Common Stock | 754,366 | 713,096 | 730,340 | 690,175 | 679,713 | 594,072 | Upgrade
|
| Additional Paid-In Capital | -33,435 | -31,606 | 7,865 | 7,286 | 7,175 | - | Upgrade
|
| Retained Earnings | -309,716 | -266,271 | -294,797 | -246,151 | -259,601 | -27,954 | Upgrade
|
| Comprehensive Income & Other | -14,028 | -4,209 | -4,321 | -798.76 | 2,649 | 8,843 | Upgrade
|
| Total Common Equity | 397,187 | 411,010 | 439,087 | 450,511 | 429,936 | 574,961 | Upgrade
|
| Minority Interest | 85,378 | 97,301 | 76,414 | 95,724 | - | - | Upgrade
|
| Shareholders' Equity | 482,565 | 508,311 | 515,502 | 546,235 | 429,936 | 574,961 | Upgrade
|
| Total Liabilities & Equity | 665,841 | 745,654 | 711,720 | 741,600 | 499,813 | 604,166 | Upgrade
|
| Total Debt | 88,621 | 144,179 | 89,667 | 115,561 | 4,249 | 7,771 | Upgrade
|
| Net Cash (Debt) | -3,657 | 29,533 | 132,825 | 185,851 | 299,020 | 451,582 | Upgrade
|
| Net Cash Growth | - | -77.77% | -28.53% | -37.85% | -33.78% | 892.04% | Upgrade
|
| Net Cash Per Share | -60.82 | 490.33 | 2215.00 | 3092.56 | 4975.70 | 8751.18 | Upgrade
|
| Filing Date Shares Outstanding | 59.74 | 60.19 | 300.48 | 300.48 | 300.48 | 300.48 | Upgrade
|
| Total Common Shares Outstanding | 59.74 | 60.19 | 300.48 | 300.48 | 300.48 | 300.48 | Upgrade
|
| Working Capital | 3,168 | 44,682 | 104,494 | 176,588 | 269,771 | 445,890 | Upgrade
|
| Book Value Per Share | 6649.00 | 6828.29 | 1461.28 | 1499.30 | 1430.83 | 1913.47 | Upgrade
|
| Tangible Book Value | 354,488 | 370,424 | 396,976 | 410,442 | 425,647 | 574,510 | Upgrade
|
| Tangible Book Value Per Share | 5934.22 | 6154.01 | 1321.13 | 1365.95 | 1416.55 | 1911.97 | Upgrade
|
| Land | 27,651 | 27,332 | 27,704 | 26,567 | 12,055 | - | Upgrade
|
| Buildings | 127,456 | 136,640 | 77,472 | 76,415 | - | - | Upgrade
|
| Machinery | 47,078 | 79,512 | 72,427 | 51,848 | 10,175 | 3,455 | Upgrade
|
| Construction In Progress | 90,920 | 110,263 | 152,876 | 169,147 | 15,415 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.